Metastatic Tumours

  • C. S. B. Galasko
  • I. Isherwood


Bone Metastasis Skeletal Metastasis Metastatic Bone Disease Osseous Metastasis Urinary Hydroxyproline 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. Adams JE, Isherwood I (1983) Conventional and new techniques in radiological diagnosis. In: Stoll BA, Parbhoo S (eds.) Bone metastasis, monitoring and treatment. Raven Press, New York, pp. 107–148Google Scholar
  2. Alexander JL, Gillespie PJ, Edelstyn GA (1976) Serial bone scanning using technetium-99m diphosphonate in patients under- going clinical combination chemotherapy for advanced breast cancer. Clin Nucl Med 1: 13–17CrossRefGoogle Scholar
  3. Bertin KC, Horstman J, Coleman SS (1984) Isolated fracture of the lesser trochanter in adults: an initial manifestation of metastatic malignant disease. J Bone Joint Surg [Am] 66: 770–773PubMedGoogle Scholar
  4. Bishop MC, Hardy JG, Taylor MC, Wastie ML, Lemberger RJ (1985) Bone imaging and serum phosphatases in prostatic Carcinoma. Br JUrol 57: 317–324CrossRefGoogle Scholar
  5. Calkins AR, Olson MA, Ellis JH (1986) Impact of myelography on the radiotherapeutie management of malignant spinal cord compression. Neurosurgery 19: 614–616PubMedCrossRefGoogle Scholar
  6. Citrin DL, Hougen C, Zweibel, W, et al. (1981) The use of serial bone scans in assessing response of bone metastases to systemic treatment. Cancer 47: 680–685PubMedCrossRefGoogle Scholar
  7. Constable AR, Cranage RW (1981) Recognition of the superscan in prostatic bone scintigraphy. Br J Radiol 54: 122–125PubMedCrossRefGoogle Scholar
  8. Coombes RC, Dady P, Parsons C et al. (1983) Assessment of response of bone metastases to systemic treatment in patients with breast cancer. Cancer 52: 610–614PubMedCrossRefGoogle Scholar
  9. Cuschieri A, Jarvie R, Taylor WH, Cant E, Furnival CM, Blumgart LH (1978) Three-centre study on urinary hydroxyproline excretion in cancer of the breast. Br J Cancer 37: 1002–1005PubMedCrossRefGoogle Scholar
  10. De Luca SA, Castronovo FP, Rhea JT (1983) The effects of chemotherapy on bony metastases as measured by quantitative skeletal imaging. Clin Nucl Med 8: 11–13CrossRefGoogle Scholar
  11. Edelstyn GA, Gillespie PJ, Grebbel FS (1967) the radiological dem- onstration of osseous metastases. Experimental observations. Clin Radiol 18: 158–162PubMedCrossRefGoogle Scholar
  12. Ell PJ, Dixon JH, Abdullah AZ (1980) Unusual spread of juxta cortical osteosarcoma. J Nucl Med 21: 190–191Google Scholar
  13. Epstein DA, Stern H (1977) The lateral view in radionuclide imaging of the sacrum. Radiology 123: 704PubMedGoogle Scholar
  14. Fidler M (1981) Incidence of fracture through metastases in long bones. Acta Orthop Scand 52: 623–627PubMedCrossRefGoogle Scholar
  15. Front D, Schenck SO, Frankel A, Robinson E (1979) Bone metastases and bone pain in breast cancer. Are they closely associated? JAMA 242: 1747–1748PubMedCrossRefGoogle Scholar
  16. Galasko CSB (1972) Skeletal metastases and mammary cancer. Ann R Coli Surg Engl 50: 3–28Google Scholar
  17. Galasko CSB (1973) Skeletal scintigraphy. In: Gilliland I, Peden M (eds) The scientific basis of medicine annual reviews 1973. Athlone Press, London, pp 187–202Google Scholar
  18. Galasko CSB (1975) The significance of occult skeletal metastases, detected by skeletal scintigraphy, in patients with otherwise apparently “early” mammary Carcinoma. Br J Surg 62: 694–696PubMedCrossRefGoogle Scholar
  19. Galasko CSB (1984a) Irradiated bone. In: Galasko CSB, Weber DA (eds) Radionuclide scintigraphy in orthopaedics. Churchill Livingstone, Edinburgh, pp 210–214Google Scholar
  20. Galasko CSB (1984b) Tumours. In: Galasko CSB, Weber DA (eds) Radionuclide scintigraphy in orthopaedics. Churchill Livingstone, Edinburgh, pp 65–109Google Scholar
  21. Galasko CSB (1986) Skeletal metastases. Butterworths, LondonGoogle Scholar
  22. Galasko CSB, Doyle FG (1972a) The response to therapy of skeletal metastases from mammary cancer. Assessment by scintigraphy. Br JSurg 59: 85–88CrossRefGoogle Scholar
  23. Galasko CSB, Doyle FH (1972b) The detection of skeletal metastases from mammary cancer. A regional comparison between radiology and scintigraphy. Clin Radiol 23: 295–297PubMedCrossRefGoogle Scholar
  24. Galasko CSB, Sylvester BS (1978) Back pain in patients treated for malignant tumours. Clin Oncol 4: 273–283PubMedGoogle Scholar
  25. Galasko CSB, Bush H, Sutton ML (1982) Tumours ofbone, car- tilage and synovium. In: Halnan KE (ed) Treatment of cancer. Chapman and Hall Ltd, London, pp 623–651Google Scholar
  26. Gielen F, Dequeker J, Drochmans A, Wildiers J, Merlevde M (1976) Relevance of hydroxyproline excretion to bone metastasis in breast cancer. Br J Cancer 34: 279–285PubMedCrossRefGoogle Scholar
  27. Gillespie PJ, Alexander JL, Edelstyn GA (1975) Changes in 87mSr concentrations in skeletal metastases in patients responding to cyclical combination chemotherapy for advanced breast cancer. J Nucl Med 16: 191–193PubMedGoogle Scholar
  28. Golimbu M, Golimbu C, Firooznia H, Rafii M, Al-Askari S, Morales P (1986) Spongious bone density determination for Staging and follow-up of patients with prostatic cancer. Urology 28: 534–539PubMedCrossRefGoogle Scholar
  29. Grainger R, Reda M, Fitzpatrick JM (1984) Calcium excretion inmetastatic prostatic Carcinoma. Br J Urol 56: 687–689PubMedCrossRefGoogle Scholar
  30. Greenburg EJ, Chu FCH, Dwyer AJ, Ziminski EM, Dimich AB, Laughlin JS (1972) Effects of radiation therapy on bone lesions as measured by 47-Ca and 85-Sr local kinetics. J Nucl Med 13: 747–751PubMedGoogle Scholar
  31. Hammond N, Jones SE, Salmon SE, Patton D, Woolfenden J (1978) Predictive value of bone scans in an adjuvant breast cancer Programme. Cancer 41: 138–142PubMedCrossRefGoogle Scholar
  32. Hayward JL, Carbone PP, Heuson J-C, Kumaoka S, Segaloff A, Rubens RD (1977) Assessment of response to therapy in advanced breast cancer. A project of the Programme on clinical oncology of the International Union against Cancer. Cancer 39: 1289–1294PubMedCrossRefGoogle Scholar
  33. Hortobagyi GN, Libshitz HI, Seabold JE (1984) Osseous metastases of breast cancer. Clinical, biochemical, radio-graphic and scintigraphic evaluation of response to therapy. Cancer 53: 577–582PubMedCrossRefGoogle Scholar
  34. Langhammer H, Sintermann R, Hor G, Pabst HW (1978) Serial bone scintigraphy for assessing the effectiveness of treatment of osseous metastases from prostatic cancer. Nuklearmedizin 17: 87–91PubMedGoogle Scholar
  35. Langhammer H, Sintermann R, Hör G, Pabst HW (1978) Serial results of serial bone scintigraphy in prostatic cancer. Nucl Med Commun 2: 110Google Scholar
  36. Levenson RM Jr, Sauerbrunn BJ, Ihde DC, Bunn PA Jr, Cohen MH, Minna JD (1981) Small cell lung cancer: radionuclide bone scans for assessment of tumour extent and response. AJR 137: 31–35PubMedGoogle Scholar
  37. Makoha FW, Britton KE (1980) Reversion of a “hot” spot to a “cold” spot in untreated metastatic bone disease - a case report. Nucl Med Comm 1: 233–238Google Scholar
  38. Merrick MV (1973) Detection of skeletal metastases. A com¬parison of three radioisotopic techniques using 18F and radiology. Br J Radiol 46: 968–971PubMedCrossRefGoogle Scholar
  39. Mettler FA Jr, Guiberteau MJ (1983) Essentials of nuclear medicine imaging. Grane and Stratton, Orlando, Florida.Google Scholar
  40. Niell HB, Palmieri GM, Neely CL, McDonald MW (1981) Postab- sorptive urinary hydroxyproline test in patients with metastatic bone disease from breast cancer. Arch Intern Med 141: 1471–1473PubMedCrossRefGoogle Scholar
  41. Parbhoo SP (1985) Usefulness of current techniques in detecting and monitoring bone metastases from breast cancer. J R Soc Med 78 [suppl 9]: 7–10PubMedGoogle Scholar
  42. Pollen JJ, Shlaer WJ (1979) Osteoblastic response to successful treatment of metastatic cancer of the prostate. AJR 132: 927–931PubMedGoogle Scholar
  43. Powles TJ, Leese CL, Bondy PK (1975) Hydroxyproline excretion in patients with breast cancer and response to treatment. Br Med J 2: 164–166PubMedCrossRefGoogle Scholar
  44. Rafii M, Firooznia H, Golimbu C, Beranbaum E (1986) CT of skeletal metastasis. Sem Ultrasound CT MR 7: 371–379Google Scholar
  45. Roberts JG, Baum M (1975) Predictive value of hydroxyproline Creatinine ratio in advanced breast cancer. Br Med J 2: 559PubMedCrossRefGoogle Scholar
  46. Rodichok LD, Ruckdeschel JC, Harper GR, et al. (1986) Early detection and treatment of spinal epidural metastases: the role of myelography. Ann Neurol 20: 696–702PubMedCrossRefGoogle Scholar
  47. Stone AR, Merrick MV, Chisholm GD (1980) The bone scan as a monitor of prostatic cancer. Clin Oncol 6: 349–360PubMedGoogle Scholar
  48. Sy WM, Patel D, Faunce H (1975) Signiflcance of absent or faint kidney sign on bone scan. J Nucl Med 16: 454–456PubMedGoogle Scholar
  49. Turner P, Haggith JW (1981) Preoperative radionuclide scanning in bronchogenic Carcinoma. BrJ Dis Chest 75: 291–294PubMedCrossRefGoogle Scholar
  50. Williams MR, Morris AH, Woolfson A, Campbell FC, Blamey RW (1984) Urinary calcium excretion as a marker of response to treatment in bone metastases from Carcinoma of the breast. Paper presented to Surgical Research Society MeetingGoogle Scholar
  51. Winchester DP, Sener SF, Khandekar JD et al. (1979) Symptomatology as an indicator of recurrent or metastatic breast cancer. Cancer 43:956–960PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 1989

Authors and Affiliations

  • C. S. B. Galasko
  • I. Isherwood

There are no affiliations available

Personalised recommendations